mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-06 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
3e-06 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
5e-06 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
6e-06 |
mRNA |
Imatinib |
GDSC1000 |
pan-cancer |
AAC |
0.27 |
6e-06 |